Japan Research IDs Leukemia Cell Points For Targeting Drug Treatments
This article was originally published in PharmAsia News
Japanese researchers report identification of 25 points on leukemia cells that could be used as the basis for new treatment
You may also be interested in...
Private Company Edition: Also, Medicxi’s new €200m fund will be reinvested in a portfolio of six life science companies and Silverback more than doubled its 2020 money with an $85m series C round.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.